Our state of the art bioanalytical lab is one of the leading labs for small-molecule bioanalysis in the US.
Our Sponsors cut weeks from their early-phase programs by utilizing our onsite bioanalytical laboratory. We provide expedited analysis for dose-escalation.
Our bioanalytical capabilities are fully integrated to support and advance your studies during early Phase I. Our experts will ensure the analytical method of choice is suitable for your early Phase I needs.
We develop and validate methods, ensuring they conform to all global regulatory requirements. If the method is already developed, we will transfer and re-validate it fully.
Our bioanalytical laboratory is equipped to handle 15,000+ samples per month, ensuring that sample analysis for your studies is performed in a matter of days.
Did you know? We have access to more than 500 validated assays and we can develop and validate an assay within 4 weeks.
Our late-stage bioanalytical offering seamlessly connects with CROs and clinical sites for Phase II-IV trials. Our bioanalytical team works with CRO project managers and CRAs to ensure on-time availability of PK sample kits at all sites while maintaining appropriate masking.
The process for dispatch, shipping, and collection of samples is closely monitored to ensure temperature control is maintained and documented in coordination with partner courier agencies.
The PK sample results are rapidly provided according to Data Transfer Agreements. A complete bioanalytical report per ICH M10 norms is generated at the end of your study for regulatory submission.
We have successfully delivered end-to-end bioanalytical services for large Phase III studies with sites across the US, Asia, and Europe.
The Scinote® ELN system and Thermo Scientific Watson® LIMS are used for all data collection, processing, and reporting. This provides a complete audit trail, ensuring compliance with global regulatory guidelines.
Our bioanalytical laboratory was audited by the FDA as recently as 2023 with no 483s.
Scroll to see more